about
Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal modelMRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2.Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsisEarly vessel destabilization mediated by Angiopoietin-2 and subsequent vessel maturation via Angiopoietin-1 induce functional neovasculature after ischemia.In vivo monitoring of sorafenib therapy effects on experimental prostate carcinomas using dynamic contrast-enhanced MRI and macromolecular contrast media.Gene therapy for ischemic heart disease.Adjuvant early and late cardioprotective therapy: access to the heart.Targeting microRNAs for cardiovascular therapeutics in coronary artery disease.VEGF-B: a more balanced approach toward cardiac neovascularization?Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas.Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model.Diabetes Mellitus-Induced Microvascular Destabilization in the Myocardium.Regulation of monocyte cell fate by blood vessels mediated by Notch signalling.Thymosin β4 attenuates microcirculatory and hemodynamic destabilization in sepsis.Heme Oxygenase-1 Gene Therapy Provides Cardioprotection Via Control of Post-Ischemic Inflammation: An Experimental Study in a Pre-Clinical Pig Model.Thymosin beta4: a key factor for protective effects of eEPCs in acute and chronic ischemiaThymosin-β4-mediated therapeutic neovascularization: role of the PI3K/AKT pathway.Adeno-associated viral vector 2.9 thymosin ß4 application attenuates rejection after heart transplantation: results of a preclinical study in the pig.Recombinant adeno-associated virus-based gene transfer of cathelicidin induces therapeutic neovascularization preferentially via potent collateral growth.Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: comparison with surgical and percutaneous intramyocardial gene delivery.Selective retroinfusion of GSH and cariporide attenuates myocardial ischemia-reperfusion injury in a preclinical pig model.Heat shock protein 90 transfection reduces ischemia-reperfusion-induced myocardial dysfunction via reciprocal endothelial NO synthase serine 1177 phosphorylation and threonine 495 dephosphorylation.Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion role of vessel maturation.Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.Retroinfusion of embryonic endothelial progenitor cells attenuates ischemia-reperfusion injury in pigs: role of phosphatidylinositol 3-kinase/AKT kinase.Hemodynamic and vascular effects of ventricular sourcing by stent-based ventricle to coronary artery bypass in patients with multivessel disease undergoing coronary artery bypass surgery.C-terminal variable AGES domain of Thymosin β4: the molecule's primary contribution in support of post-ischemic cardiac function and repair.Endothelial nitric oxide synthase overexpression provides a functionally relevant angiogenic switch in hibernating pig myocardium.SDF-1 fused to a fractalkine stalk and a GPI anchor enables functional neovascularization.Percutaneous approach to a stent-based ventricle to coronary vein bypass (venous VPASS): comparison to catheter-based selective pressure-regulated retro-infusion of the coronary vein.First clinical experience with the VSTENT: a device for direct left ventricle-to-coronary artery bypass.Endothelial RAGE exacerbates acute postischaemic cardiac inflammation.Annexin A1 counteracts chemokine-induced arterial myeloid cell recruitment.NF kappaB activation in embryonic endothelial progenitor cells enhances neovascularization via PSGL-1 mediated recruitment: novel role for LL37.VEGF165 transfection decreases postischemic NF-κB-dependent myocardial reperfusion injury in vivo: role of eNOS phosphorylationSelective Pressure-Regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemiaFeasibility of dynamic CT-based adenosine stress myocardial perfusion imaging to detect and differentiate ischemic and infarcted myocardium in an large experimental porcine animal modelPerfusion MRI for Monitoring the Effect of Sorafenib on Experimental Prostate Carcinoma: A Validation StudyAccuracy of Dynamic Computed Tomography Adenosine Stress Myocardial Perfusion Imaging in Estimating Myocardial Blood Flow at Various Degrees of Coronary Artery Stenosis Using a Porcine Animal ModelMitochondrial Thioredoxin Reductase Is Essential for Early Postischemic Myocardial Protection
P50
Q28243737-4BD3C72A-AE0D-4101-B3C4-CA5B4E01E009Q30317274-E1D6B344-2DF9-49A0-BB2B-29883F31422CQ30541878-27AE8984-B772-4B6C-8439-DC325295BE3BQ34685212-C69A5A51-8264-4700-A3B6-7E1807E06919Q37422783-35CB08A2-A8B5-4A51-953C-B655CAE7E763Q37857290-C21729ED-CDB5-4065-8857-4FE171269BFDQ37982681-2C950F28-F619-4E95-8109-AC98A0BD3594Q38243528-512E04F1-A637-4EA7-8D22-8530CCCB218CQ38334257-AF358CC9-E589-459F-BDC4-1C3BC0173950Q39470823-29C66DCD-3C9F-4169-A7E2-C1A8B8DFD41FQ40036183-DC8A11C5-499A-4EE3-BCDE-CAAE5BC2BBC8Q40383352-55C83D67-F40E-4DE7-8939-93E840F2F71AQ41030514-D6DE44BB-6B8A-41D2-9E56-76F225114A38Q41532527-20693785-9EE6-4D93-A8AF-220D6CD3F346Q41598382-C35A01BB-D787-491B-AC17-507A8EEF3AA4Q41892971-A5F0323C-6E2A-4584-B501-D31FD56DB723Q42172475-872C4ACD-13B6-4503-9F93-AECA71FE5FD7Q42183440-0E6111F1-A779-436D-B508-78E8AF8FD71EQ43106112-84B0EA1B-974D-4B16-BE16-DD2FF06A72F9Q43670453-CADBFD93-94B9-49FB-8FDE-53BEE16DB74DQ44763879-F38B5A60-9B0C-4541-B99B-F96FBE046469Q44922338-216BD084-7010-457F-8E14-105F16FAB384Q45374311-E22CF5D2-6011-4389-9FA4-A4AE47E93462Q45872017-FB57FF76-6215-49CC-8DD8-6D5B9DAEABAFQ46700935-1FD3A13E-B37D-4FED-9582-883CA875409EQ46700988-D56F15BE-6C0A-4C52-ABC7-EC2AB471F122Q50571979-F8D59A85-AC9B-42B1-A66F-C10B73E534ECQ50690119-B472F1CA-96A4-4577-B877-CBC18AA308A8Q50929234-CAD28072-CF4B-412A-ADB6-32ED0B921DEDQ51535791-B2A2BB42-4F6B-4E9E-8EAB-C0EBCC55D9F9Q51547099-EE8A3541-0B6B-4D5F-8548-6A63D6C13A1CQ53066698-33A8ED3B-4265-44B0-8031-F246772D9516Q53665256-8E478FD6-8166-49ED-8467-CDFCBF918BF1Q54450087-BDE40C46-4C4A-4B06-A1B7-471FBB53B232Q58816352-B6DBD700-3A97-4854-94AE-4787F50E2B3EQ59261110-98E76BB9-81B0-490C-B904-CA697C844C12Q59689390-047AECF3-3870-4C74-82C3-90C7CFF02D7DQ59689546-78359897-2F68-4E27-9546-3838B9C62169Q59689552-4F4D4A85-9ECA-4E58-ABFC-13DF658918F2Q60606962-1A723797-C23B-49F8-9EDB-2DD59472A09F
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rabea Hinkel
@ast
Rabea Hinkel
@en
Rabea Hinkel
@es
Rabea Hinkel
@nl
Rabea Hinkel
@sl
type
label
Rabea Hinkel
@ast
Rabea Hinkel
@en
Rabea Hinkel
@es
Rabea Hinkel
@nl
Rabea Hinkel
@sl
prefLabel
Rabea Hinkel
@ast
Rabea Hinkel
@en
Rabea Hinkel
@es
Rabea Hinkel
@nl
Rabea Hinkel
@sl
P1053
I-9165-2014
P106
P1153
6602448278
P21
P31
P3829
P496
0000-0002-2936-0400
P569
2000-01-01T00:00:00Z